YOLFTbeta
68

Suzhou Sepax Technologies Co Ltd Ordinary Shares - Class A

688758 · SHG · Basic Materials / Chemicals

22.53CNY-1.31 (-5.49%)

Price History

Full chart

Market Stats

Previous Close23.84
Open23.79
Day Range22.45 – 23.90
52-Week Range15.81 – 34.79
Volume7.96M
Market Cap12.55B
P/E (TTM)68.48
Forward P/E0.00
EPS0.44
Dividend Yield0.32%
50-Day Avg27.91
200-Day Avg21.63

About

Suzhou Sepax Technologies Co., Ltd., a high-tech company, engages on the research, development, production, and sale of liquid chromatography materials and technologies worldwide. Its products are chromatographic columns and chromatographic fillers used in the analysis, detection, separation and purification of biological macromolecule drugs and small molecule chemical drugs. The company's analytical chromatography products are used for analytical testing in drug development and quality inspection. Suzhou Sepax Technologies Co., Ltd. was founded in 2002 and is headquartered in Suzhou, China.

Company Details

  • SectorBasic Materials
  • IndustryChemicals
  • CEODr. Xueying Huang
  • Employees459
  • HeadquartersSuzhou Saifen Technology R&D Office Building, Suzhou, China, 215123, China
  • Websitehttps://www.sepax-tech.com.cn

Leadership

  • Dr. Xueying HuangGM & Chairman of the Board · b. 1967
  • Mr. Zhu ZhaojinChief Financial Officer · b. 1978
  • Mr. Ni HaoDirector and GM of US-based Ceftrix Biotech & Ceftrix Biotech · b. 1974
  • Ms. Wang ZhongleiBoard Secretary · b. 1996
  • Mr. Sun KeDeputy General Manager · b. 1974
  • Xi Ya WangAccounting Supervisor
  • Dr. Huiming MaoTechnical Director · b. 1979
  • Dr. Hongyu WangGlobal Chief Quality Officer · b. 1964
  • Dr. Mathew GeorgeDirector of R&D Department · b. 1967
  • Mr. Xiaotao ZhouDirector of Operations of US Division · b. 1975

Financials

Income Statement

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Revenue212.77M245.21M315.46M402.93M
Growth (%)-+15.24%+28.65%+27.73%
Cost of Revenue50.37M70.61M91.51M115.25M
Gross Profit162.40M174.60M223.95M287.68M
Gross Margin76.33%71.21%70.99%71.40%
Operating Expense117.97M120.16M126.48M146.62M
Operating Income44.43M54.44M97.47M141.06M
Operating Margin20.88%22.20%30.90%35.01%
EBITDA69.92M81.83M121.66M166.98M
EBITDA Margin32.86%33.37%38.57%41.44%
Net Income47.14M52.49M85.16M126.54M
Net Income Margin22.15%21.40%27.00%31.40%
R&D40.68M44.21M42.88M55.08M
R&D as % of Total Revenue19.12%18.03%13.59%13.67%
Interest Expense1.75M1.72M1.53M1.40M
Interest Expense % of Total Revenue0.82%0.70%0.48%0.35%

Balance Sheet

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Total Assets1.05B1.10B1.18B1.45B
Total Liabilities100.67M96.17M84.27M90.27M
Total Equity940.91M997.54M1.09B1.35B
Cash335.33M258.79M103.08M183.86M

Cash Flow

Currency: CNY2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow28.54M43.37M66.01M102.55M
Capital Expenditure48.74M19.13M13.54M14.00M
Free Cash Flow-20.20M24.23M52.48M88.55M
Dividends Paid51.45K--27.91M
FCF to OCF-70.76%55.88%79.49%86.35%
Dividend Paid to FCF-0.25%--31.52%

Key Statistics & Ratios

Market Cap12.55B
Enterprise Value13.53B
Trailing P/E68.48
Forward P/E0.00
Price / Sales25.09
Price / Book10.09
EPS0.44
Book Value3.33
Revenue (TTM)500.04M
Gross Profit (TTM)363.82M
EBITDA195.14M
Profit Margin36.70%
Operating Margin46.79%
Return on Equity13.65%
Return on Assets7.67%
Shares Outstanding416.46M
Shares Float149.33M
Dividend Yield0.32%
Dividend Rate0.10
Payout Ratio5.88%

Dividends

20261×
0.07Jul 22, 2026
20252×
0.03Sep 24, 20250.04Jun 13, 2025